Description
During the past three decades since its invention, PCR has evolved to become one of the fundamental technology platforms in life sciences sector. The application segments of this platform are still expanding, driven by the expiry of key PCR patents. The demand for fast, accurate, and affordable diagnosis tests in healthcare segment has been another key driver of the PCR market. The rising investments in the field of companion diagnostics have also been boosting the demand for PCR. Food safety testing is another significant end-use segment of the technology, driven by both consumer demand and regulatory requirements. In this report titled “The North American Markets for PCR Technologies”, analysts identify the market dynamics in North America and forecasts the potential of the market related to product segments, technology segments, and end-use segments. The North American market, which accounted for approximately 40% of the global demand for PCR technologies, is expected to grow at a CAGR of around 6% during 2013-2018. The report estimates the market size of the key product and application segments of PCR and forecasts the growth based on market dynamics of these segments, which can impact the demand for PCR. Various technology segments are also analysed in detail. The study assesses alternate platforms that can potentially impact the demand for PCR. Evolving trends with respect to various aspects of PCR technology are also analysed in detail. This is followed by patent analysis to identify the most active areas within PCR market that are gaining attention and investment by stake holders. Regulatory landscape of the key regional markets and end-use segments are also included in the report, since regulatory requirements directly impact the demand for PCR based tests. Finally, the report analyses the activities of key players in the North American market. Nearly 50 company profiles are included in the report, which includes leading multinational companies as well as small and medium companies with promising platforms and products. Study Goal And Outline Rationale For This Study Targeted Audience Market Definition And Scope Information Sources And Methodologies Customization Of This Study Disclaimer EXECUTIVE SUMMARY CHAPTER 1: OVERVIEW Definition Of Polymerase Chain Reaction History Of PCR Table 1: Timeline Of PCR Technology History (1983 – 2013) Table 2: Timeline Of Real-Time PCR History Table 3: Timeline Of Digital PCR History The Concept Important Considerations Table 4: Some Important Factors To Be Considered While Planning PCR Experiments PCR Platforms – Popular And Emerging Allele-Specific PCR (AsPCR) Amplified Fragment Length Polymorphisms PCR (Aflp-PCR) Assembly PCR Asymmetric PCR Capillary PCR Colony PCR Table 5: Key Players And Their Products In The Field Of Colony PCR Digital PCR (DPCR) Table 6: Key Players And Their Products In The Field Of Digital PCR Direct PCR Table 7: Key Players And Their Products In The Field Of Direct PCR Hot-Start PCR Table 8: Key Players And Their Products In The Field Of Hot-Start PCR Situ PCR Table 9: Key Players And Their Products In The Field Of In Situ PCR Inter-Simple Sequence Repeat PCR (Issr-PCR) Inverse PCR Long PCR Table 10: Key Players And Their Products In The Field Of Long PCR Long Accurate PCR (La PCR) Table 11: Key Players And Their Products In The Field Of Long Accurate PCR Methylation-Specific PCR Table 12: Key Players And Their Products In The Field Of Methylation-Specific PCR Mini Primer PCR Multiplex PCR Table 13: Key Players And Their Products In The Field Of Multiplex PCR Nanoparticle Assisted PCR (Nano PCR) Nested PCR Table 14: Key Players And Their Products In The Field Of Nested PCR Overlap-Extension PCR (Oe-PCR) Quantitative Fluorescence PCR (Qf-PCR) Table 15: Key Players And Their Products In The Field Of Quantitative Fluorescence PCR Random Amplified Polymorphic Dna (Rapd) PCR Table 16: Key Players And Their Products In The Field Of Random Amplified Polymorphic Dna PCR Real-Time PCR Table 17: Commonly Used Detection Chemistries In Real-Time PCR Table 18: Key Players And Their Products In The Field Of Real-Time PCR Repetitive Sequence-Based PCR (Rep-PCR) Reverse Transcription PCR (Rt-PCR) Table 19: Key Players And Their Products In The Field Of Reverse Transcription PCR Single Cell PCR Table 20: Key Players And Their Products In The Field Of Single Cell PCR Solid Phase PCR Thermal Asymmetric Interlaced PCR (Tail-PCR) Touchdown PCR Universal Fast Walking PCR (Ufw) Table 21: Key Players And Their Products In The Field Of Universal Fast Walking PCR End-Use Segments Of PCR Medical Diagnostics Segments Cancer Table 22: Key Players Offering PCR-Based Cancer Diagnostics Products In The Market Infectious Diseases Table 23: Key Players Offering PCR-Based Diagnostics Products Targeting Human Infections Prenatal Diagnostics Table 24: Key Players Offering PCR-Based Prenatal Diagnostics Products In The Market Food Safety Testing, Agricultural, And Environmental Segments Food-Borne And Water-Borne Infections Table 25: Common Commercial Systems Used For Food Pathogen Detection I. Campylobacter And Its Subspecies (Campylobacter Spp.) Table 26: International Standards And Guidelines For Campylobacter Spp. Identification Table 27: Key Players Offering PCR-Based Kits To Detect Campylobacter And Its Subspecies II. Escherichia Coli (E. Coli) Table 28: International Standards And Guidelines For Escherichia Coli Detection Table 29: Key Players Offering PCR-Based Kits To Detect Pathogenic Escherichia Coli And Its Subspecies III. Listeria Monocytogenes And Its Subspecies (Listeria Spp.) Table 30: International Standards And Guidelines For Listeria Detection Table 31: Key Players Offering PCR-Based Kits To Detect Listeria Monocytogenes And Its Subspecies IV. Salmonella And Its Subspecies (Salmonella Spp.) Table 32: International Standards And Guidelines For Salmonella Detection Table 33:Key Players Offering PCR-Based Kits To Detect Salmonella And Its Subspecies V. Other Food-Borne And Water-Borne Pathogens Table 34: Key Players Offering PCR-Based Kits To Detect Other Selected Food-Borne And Water-Borne Pathogens Veterinary Infection Diagnostics Table 35: Key Players Offering PCR-Based Veterinary Diagnostics Products Plant Infection Diagnostics Table 36: Key Players Offering PCR-Based Diagnostics Products Targeting Plant Infections Gmo Foods/Plants Testing Table 37: Key Players Offering PCR-Based Kits To Detect Gmo Foods/Plants In The Market Food Allergens And Animal Species In Food Table 38: Key Players Offering PCR-Based Kits To Detect Food Allergens And Animal Species In Food In The Market Forensic Sciences Table 39: Key Players Offering PCR-Based Human Identity And Forensic Testing Products In The Market Life Sciences Research miRNA Analysis Table 40: Key Players Offering Products For Microrna Analysis Involving PCR Technology Mutations Detection Table 41: Key Players Offering PCR-Based Mutations Detection Products SNP Detection And Genotyping Table 42: Key Players Offering PCR-Based Products For Snps Detection And Genotyping Sequencing Table 43: Key Players Offering PCR-Based Sequencing Products Application Of PCR In Ngs Library Quantification Table 44: Key Players Offering Ngs Library Quantification Products That Incorporate PCR Technology Genetic Fingerprinting Table 45: Key Players Offering PCR-Related Products For Genotyping/DNA Fingerprinting Site-Directed Mutagenesis (SDM) Table 46: Key Players Offering PCR-Based Site-Directed Mutagenesis Products Market Trends Widening Application Scope Patent Expiries During The Forecast Period Table 47: Basic PCR Patents Expired In 28 March 2005 In USA Table 48: Key Patents In Selected PCR Market Segments And Their Expiry Dates In USA Dominance Of PCR Over Alternative Pathogen Diagnostics Options Technological Advancements Enabling High Throughput As Well As Point-Of-Care (Poc) Diagnostics Advent Of Digital PCR Strong Growth Trends In Single-Cell Analysis (SCA) The Rising Demand For Molecular Diagnostics The Rising Food Safety Testing Regulations Market Drivers Table 49: Market Drivers Of The North American PCR Market Market Challenges Table 50: Market Restraints Of The North American PCR Markets The Rising Merger And Acquisition Trends Table 51: Key Mergers And Acquisitions During The Past Five Years Relevant In PCR Market (2010-2014) CHAPTER 2: INDUSTRY STRUCTURE Table 52: Global PCR Technology Markets, By Value (USD, Million) Figure 1: Market Shares And Forecasts Of Global PCR Technology Market Segments The North American Markets Table 53: PCR Market Segments And Their Growth Trends In North America, By Value (USD, Million) Analysis Of Key End-Use Segments Table 54: Global PCR Technologies Demand By End-Use Segments, By Value (USD, Million) Table 55:PCR Technologies Demand By End-Use Segments In North America, By Value (USD, Million) Medical Diagnostics Food, Agriculture, Etc. Life Sciences Research Figure 2: Market Shares And Forecasts Of PCR Technologies Demand By End-Use Segments CHAPTER 3: LEGISLATION AND REGULATION MIQE Guidelines And R|DML Regulatory Landscape Of PCR Technologies In Medical Diagnostics Fields Table 56: Regulatory Agencies Responsible For Molecular Diagnostics In North America Table 57: Regulatory Agencies Influencing Genetic Testing In USA Table 58: Laws And Regulations Influencing PCR-Based Medical Diagnostics Markets In USA Regulation Of Laboratory Developed Tests (Ldts) In USA Table 59: Key Laws And Regulations Influencing PCR-Based Medical Diagnostics Markets In Canada Regulatory Landscape Of PCR Technologies Targeting Food And Agricultural Segments Table 60: Main International Agencies Involved In Food Safety Aspects Table 61: Regulatory Agencies Responsible For Food Safety Testing Regulations In USA Table 62: Food Safety Laws And Regulations Influencing PCR Technologies Markets In Usa Canada Table 63: Food Safety Laws And Regulations In Canada Forensics Table 64: Frequently Used PCR Kits Accepted At Ndis, USA CHAPTER 4: TECHNOLOGY TREND ANALYSIS Automation Of PCR Touch-Screen Options For Ease-Of-Use Networking And Remote Controlling Capabilities Low Throughput Systems Lab-On-A-Chip Formats And Portability Application Of Microelectromechanical Systems (Mems) And Convection Principles In PCR Automated High Throughput Instruments For Large Scale Applications Table 65: Selected Companies Enabling High Throughput In QPCR Table 66: Comparison Of The Reaction Formats Of Selected Real-Time PCR Instruments In The Market Evolution In Heating Technologies For Efficient Thermal Cycling Table 67: Comparison Of The Thermal Modules Of Selected Commercial Real-Time PCR Systems Speed Table 68: Comparison Of The Optical Modules Of Selected Real-Time PCR Systems In The Market Improving Multiplexing Efficiency Table 69: Technical Approaches Adopted For Limiting Off-Target Amplification In Multiplex QPCR Assays Fluorescence Chemistry Taqman Probe Molecular Beacons And Scorpions Table 70: Fluorescence Chemistry And Multiplex Capability Of Selected QPCR Systems In The Market The Early Adopters Of DPCR Widening Scope Within Molecular Biology Platforms CHAPTER 5: ASSESSMENT OF PATENTING TRENDS In PCR Field Table 71: Comparison Of Patenting Trends In Selected PCR Segments (1983 – 2013) Figure 3: PCR Platforms With Intense Patenting Activities During The Past Three Decades Table 72: Selected Patents On Digital PCR Table 73: Selected Patents On Inverse PCR Table 74: Selected Patents On Multiplex PCR Table 75: Selected Patents On Nested PCR Table 76: Selected Patents On Real-Time PCR Table 77: Selected Patents On Reverse Transcription PCR Patenting Trends In Selected End-Use Segments Of PCR Analysis Of Patenting Trends In Infectious Diseases Sector Table 78: PCR-Based Diagnostics: Patenting Trends In Selected Infected Disease Areas Analysis Of Patenting Trends In Cancer Sector Table 79: PCR-Based Diagnostics: Patenting Trends In Selected Cancer Segments Table 80: PCR-Based Diagnostics – Patenting Trends In Selected End-Use Segments The Rising Popularity Of Real-Time PCR Table 81: Assessing The Influence Of Real Time PCR In Selected End Use Segments End-Use Segments Where Digital PCR Influence Is Growing Table 82: End-Use Segments Where DPCR Patenting Activities Are Growing Patenting Trends Of Companies In The Real-Time PCR Segment Table 83: Patents By Selected Key Players Related To Real-Time PCR Patenting Trends Of Companies Within The Digital PCR Segment Table 84: Patents By Key Players Related To Digital PCR CHAPTER 6: COMPANY PROFILES Abbott Laboratories Figure 4: Abbott Revenue Shares, By Region, 2013 Actgene, Inc. Affymetrix, Inc. Table 85: Affymetrix Revenue Shares, By Business Unit, 2013 Figure 5: Affymetrix Revenue Shares, By Product Category, 2013 Agilent Technologies, Inc. Figure 6: Agilent Technologies Revenue Shares, By Business Group, 2013 Ambry Genetics Corporation Amresco, Llc Biomérieux S.A. Bio Basic Canada, Inc. Bio-Rad Laboratories, Inc. Figure 7: Bio-Rad Laboratories Revenue Shares, By Region, 2013 Table 86: Bio-Rad Laboratories Revenue Shares, By Segment, 2013 Biochain Institute, Inc. Biocontrol Systems, Inc. Bionexus, Inc. Bioserve Biotechnologies Ltd. Biotium, Inc. Bulldog Bio, Inc. Cepheid, Inc. Table 87: Clinical And Non-Clinical Revenue Shares, 2013 Figure 8: Cepheid Revenue Shares, By Region, 2013 E. I. Du Pont De Nemours And Company Epicentre Biotechnologies (An Illumina Company) Epigentek Group, Inc. Eppendorf Ag Figure 9: Eppendorf Revenue Shares, By Region, 2013 Eurofins Genomics F. Hoffmann-La Roche Ltd. Table 88: Roche Diagnostics – Main Businesses And Their Revenues, 2013 Figure 10: Roche Diagnostics Revenue Shares, By Region, 2013 Table 89: Selected PCR-Based Companion Diagnostics Under Development By Roche Fluidigm Corporation Figure 11: Fluidigm Revenue Shares, By Region, 2013 Funglyn Biotech, Inc. Gene Link, Inc. Hercuvan Lab Systems, Inc. Icubate, Inc. Illumina, Inc. Table 90: Revenue Shares Of Illumina, By Product Category, 2012-2013 (USD, Million) Figure 12: Illumina Revenue Shares, By Region, 2013 Infinigen Biotechnology, Inc. Integrated Dna Technologies, Inc. Instantlabs Invisible Sentinel, Inc. Kapa Biosystems, Inc. Kestrel Biosciences, Llc Lucigen Corporation Maxim Biotech, Inc. Merck Millipore International Figure 13: Merck Millipore Revenue Shares, By Region, 2013 Table 91: Merck Millipore Revenue Shares, By Business Segments, 2013 Molecular Cloning Laboratories (MCLAB) New England Biolabs, Inc. Norgen Biotek Corporation Pall Corporation Premier Biosoft International PrimeraDX, Inc. Promega Corporation QIAGEN N.V. Figure 14: Revenue Distribution By Customer Categories, QIAGEN, 2013 Table 92: Geographic Distribution Of QIAGEN Revenues, 2012-2013 (USD, Million) Quanta Biosciences, Inc. Raindance Technologies, Inc. Scientific Specialties Incorporated Sigma-Aldrich Corporation Table 93: Main Business Units Of Sigma-Aldrich And Their Revenue Shares, 2013 Figure 15: Revenue Shares Of Sigma-Aldrich Business Units, By Region, 2013 Takara Bio, Inc. Figure 16: Takara Bio Revenue Shares, By Business Segment, Fiscal Year 2013 Table 94: Takara Bio Revenue Shares, By Business Segment, Fiscal Year 2013 Thermo Fisher Scientific, Inc. Figure 17: Thermo Fisher Scientific Revenue Shares, By Region, 2013 Figure 18: Life Technologies Revenue Shares, By Region, 2012 Table 95: Thermo Fisher Scientific Revenue Shares, By Business Segments, 2013 Toyobo Co., Ltd Table 96: Toyobo Revenue Shares, By Business Segment, Fiscal Year 2013 Zoologix, Inc. GLOSSARY List Of Figures
Analysis Of PCR Technology Markets
USA
Detectors
Light Source
Assessing The Popularity Of PCR Platforms On The Basis Of Patenting Trends
Patenting Trends Of Key Players In The PCR Market
List Of Tables
Table 1: Timeline Of PCR Technology History (1983 – 2013)
Table 2: Timeline Of Real-Time PCR History
Table 3: Timeline Of Digital PCR History
Table 4: Some Important Factors To Be Considered While Planning PCR Experiments
Table 5: Key Players And Their Products In The Field Of Colony PCR
Table 6: Key Players And Their Products In The Field Of Digital PCR
Table 7: Key Players And Their Products In The Field Of Direct PCR
Table 8: Key Players And Their Products In The Field Of Hot-Start PCR
Table 9: Key Players And Their Products In The Field Of In Situ PCR
Table 10: Key Players And Their Products In The Field Of Long PCR
Table 11: Key Players And Their Products In The Field Of Long Accurate PCR
Table 12: Key Players And Their Products In The Field Of Methylation-Specific PCR
Table 13: Key Players And Their Products In The Field Of Multiplex PCR
Table 14: Key Players And Their Products In The Field Of Nested PCR
Table 15: Key Players And Their Products In The Field Of Quantitative Fluorescence PCR
Table 16: Key Players And Their Products In The Field Of Random Amplified Polymorphic Dna PCR
Table 17: Commonly Used Detection Chemistries In Real-Time PCR
Table 18: Key Players And Their Products In The Field Of Real-Time PCR
Table 19: Key Players And Their Products In The Field Of Reverse Transcription PCR
Table 20: Key Players And Their Products In The Field Of Single Cell PCR
Table 21: Key Players And Their Products In The Field Of Universal Fast Walking PCR
Table 22: Key Players Offering PCR-Based Cancer Diagnostics Products In The Market
Table 23: Key Players Offering PCR-Based Diagnostics Products Targeting Human Infections
Table 24: Key Players Offering PCR-Based Prenatal Diagnostics Products In The Market
Table 25: Common Commercial Systems Used For Food Pathogen Detection
Table 26: International Standards And Guidelines For Campylobacter Spp. Identification
Table 27: Key Players Offering PCR-Based Kits To Detect Campylobacter And Its Subspecies
Table 28: International Standards And Guidelines For Escherichia Coli Detection
Table 29: Key Players Offering PCR-Based Kits To Detect Pathogenic Escherichia Coli And Its Subspecies
Table 30: International Standards And Guidelines For Listeria Detection
Table 31: Key Players Offering PCR-Based Kits To Detect Listeria Monocytogenes And Its Subspecies
Table 32: International Standards And Guidelines For Salmonella Detection
Table 33: Key Players Offering PCR-Based Kits To Detect Salmonella And Its Subspecies
Table 34: Key Players Offering PCR-Based Kits To Detect Other Selected Food-Borne And Water-Borne Pathogens Table 35: Key Players Offering PCR-Based Veterinary Diagnostics Products
Table 36: Key Players Offering PCR-Based Diagnostics Products Targeting Plant Infections
Table 37: Key Players Offering PCR-Based Kits To Detect Gmo Foods/Plants In The Market
Table 38: Key Players Offering PCR-Based Kits To Detect Food Allergens And Animal Species In Food In The Market Table 39: Key Players Offering PCR-Based Human Identity And Forensic Testing Products In The Market
Table 40: Key Players Offering Products For Microrna Analysis Involving PCR Technology
Table 41: Key Players Offering PCR-Based Mutations Detection Products
Table 42: Key Players Offering PCR-Based Products For Snps Detection And Genotyping
Table 43: Key Players Offering PCR-Based Sequencing Products
Table 44: Key Players Offering Ngs Library Quantification Products That Incorporate PCR Technology
Table 45: Key Players Offering PCR-Related Products For Genotyping/Dna Fingerprinting
Table 46: Key Players Offering PCR-Based Site-Directed Mutagenesis Products
Table 47: Basic PCR Patents Expired In 28 March 2005 In Usa
Table 48: Key Patents In Selected PCR Market Segments And Their Expiry Dates In USA
Table 49: Market Drivers Of The North American PCR Market
Table 50: Market Restraints Of The North American PCR Markets
Table 51: Key Mergers And Acquisitions During The Past Five Years Relevant In PCR Market (2010-2014)
Table 52: Global PCR Technology Markets, By Value (USD, Million)
Table 53: PCR Market Segments And Their Growth Trends In North America, By Value (USD, Million)
Table 54: Global PCR Technologies Demand By End-Use Segments, By Value (USD, Million)
Table 55: PCR Technologies Demand By End-Use Segments In North America, By Value (USD, Million)
Table 56: Regulatory Agencies Responsible For Molecular Diagnostics In North America
Table 57: Regulatory Agencies Influencing Genetic Testing In USA
Table 58: Laws And Regulations Influencing PCR-Based Medical Diagnostics Markets In USA
Table 59: Key Laws And Regulations Influencing PCR-Based Medical Diagnostics Markets In Canada
Table 60: Main International Agencies Involved In Food Safety Aspects
Table 61: Regulatory Agencies Responsible For Food Safety Testing Regulations In USA
Table 62: Food Safety Laws And Regulations Influencing PCR Technologies Markets In USA
Table 63: Food Safety Laws And Regulations In Canada
Table 64: Frequently Used PCR Kits Accepted At NDIS, USA
Table 65: Selected Companies Enabling High Throughput In QPCR
Table 66: Comparison Of The Reaction Formats Of Selected Real-Time PCR Instruments In The Market
Table 67: Comparison Of The Thermal Modules Of Selected Commercial Real-Time PCR Systems
Table 68: Comparison Of The Optical Modules Of Selected Real-Time PCR Systems In The Market
Table 69: Technical Approaches Adopted For Limiting Off-Target Amplification In Multiplex QPCR Assays
Table 70: Fluorescence Chemistry And Multiplex Capability Of Selected QPCR Systems In The Market
Table 71: Comparison Of Patenting Trends In Selected PCR Segments (1983 – 2013)
Table 72: Selected Patents On Digital PCR
Table 73: Selected Patents On Inverse PCR
Table 74: Selected Patents On Multiplex PCR
Table 75: Selected Patents On Nested PCR
Table 76: Selected Patents On Real-Time PCR
Table 77: Selected Patents On Reverse Transcription PCR
Table 78: PCR-Based Diagnostics: Patenting Trends In Selected Infected Disease Areas
Table 79: PCR-Based Diagnostics: Patenting Trends In Selected Cancer Segments
Table 80: PCR-Based Diagnostics – Patenting Trends In Selected End-Use Segments
Table 81: Assessing The Influence Of Real Time PCR In Selected End-Use Segments
Table 82: End-Use Segments Where DPCR Patenting Activities Are Growing
Table 83: Patents By Selected Key Players Related To Real-Time PCR
Table 84: Patents By Key Players Related To Digital PCR A
Table 85: Affymetrix Revenue Shares, By Business Unit, 2013
Table 86: Bio-Rad Laboratories Revenue Shares, By Segment, 2013
Table 87: Clinical And Non-Clinical Revenue Shares, 2013
Table 88: Roche Diagnostics – Main Businesses And Their Revenues, 2013
Table 89: Selected PCR-Based Companion Diagnostics Under Development By Roche
Table 90: Revenue Shares Of Illumina, By Product Category, 2012-2013 (USD, Million)
Table 91: Merck Millipore Revenue Shares, By Business Segments, 2013
Table 92: Geographic Distribution Of QIAGEN Revenues, 2012-2013 (USD, Million)
Table 93: Main Business Units Of Sigma-Aldrich And Their Revenue Shares, 2013
Table 94: Takara Bio Revenue Shares, By Business Segment, Fiscal Year 2013
Table 95: Thermo Fisher Scientific Revenue Shares, By Business Segments, 2013
Table 96: Toyobo Revenue Shares, By Business Segment, Fiscal Year 2013
Figure 1: Market Shares And Forecasts Of Global PCR Technology Market Segments
Figure 2: Market Shares And Forecasts Of PCR Technologies Demand By End-Use Segments
Figure 3: PCR Platforms With Intense Patenting Activities During The Past Three Decades
Figure 4: Abbott Revenue Shares, By Region, 2013
Figure 5: Affymetrix Revenue Shares, By Product Category, 2013
Figure 6: Agilent Technologies Revenue Shares, By Business Group, 2013
Figure 7: Bio-Rad Laboratories Revenue Shares, By Region, 2013
Figure 8: Cepheid Revenue Shares, By Region, 2013
Figure 9: Eppendorf Revenue Shares, By Region, 2013
Figure 10: Roche Diagnostics Revenue Shares, By Region, 2013
Figure 11: Fluidigm Revenue Shares, By Region, 2013
Figure 12: Illumina Revenue Shares, By Region, 2013
Figure 13: Merck Millipore Revenue Shares, By Region, 2013
Figure 14: Revenue Distribution By Customer Categories, Qiagen, 2013
Figure 15: Revenue Shares Of Sigma-Aldrich Business Units, By Region, 2013
Figure 16: Takara Bio Revenue Shares, By Business Segment, Fiscal Year 2013
Figure 17: Thermo Fisher Scientific Revenue Shares, By Region, 2013
Figure 18: Life Technologies Revenue Shares, By Region, 2012
ACTGene, Inc.
Affymetrix, Inc.
Agilent Technologies, Inc.
Ambry Genetics Corporation
AMRESCO, LLC
Bio Basic Canada, Inc.
BioChain Institute, Inc.
BioControl Systems, Inc.
bioMérieux S.A.
Bionexus, Inc.
Bio-Rad Laboratories, Inc.
BioServe Biotechnologies Ltd.
Biotium, Inc.
Bulldog Bio, Inc.
Cepheid, Inc.
E. I. du Pont de Nemours and Company
Epicentre Biotechnologies (An Illumina Company)
Epigentek Group, Inc.
Eppendorf AG
Eurofins Genomics
F. Hoffmann-La Roche Ltd.
Fluidigm Corporation
Funglyn Biotech, Inc.
Gene Link, Inc.
Hercuvan Lab Systems, Inc.
iCubate, Inc.
Illumina, Inc.
Infinigen Biotechnology, Inc.
InstantLabs
Integrated DNA Technologies, Inc.
Invisible Sentinel, Inc.
Kapa Biosystems, Inc.
Kestrel BioSciences, LLC
Lucigen Corporation
Maxim Biotech, Inc.
Merck Millipore International
Molecular Cloning Laboratories (MCLAB)
New England Biolabs, Inc.
Norgen Biotek Corporation
Pall Corporation
PREMIER Biosoft International
PrimeraDx, Inc.
Promega Corporation
QIAGEN N.V.
Quanta BioSciences, Inc.
RainDance Technologies, Inc.
Scientific Specialties Incorporated
Sigma-Aldrich Corporation
Takara Bio, Inc.
Thermo Fisher Scientific, Inc.
Toyobo Co., Ltd
Zoologix, Inc.